Impact of Topical 5% Lidocaine-Medicated Plasters On Sleep And Quality Of Life In Patients With Postherpetic Neuralgia

References

• Johnson RW , RiceAS . Clinical practice. Postherpetic neuralgia . N. Engl. J. Med.371 , 1526 – 1533 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Dworkin RH , O’ConnorAB , BackonjaMet al. Pharmacologic management of neuropathic pain: evidence-based recommendations . Pain132 , 237 – 251 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Drolet M , BrissonM , SchmaderKEet al. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study . Can. Med. Assoc. J.182 , 1731 – 1736 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Oster G , HardingG , DukesE , EdelsbergJ , ClearyPD . Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey . J. Pain6 , 356 – 363 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Liedgens H , ObradovicM , NuijtenM . Health economic evidence of 5% lidocaine medicated plaster in post-herpetic neuralgia . Clinicoecon. Outcomes Res.5 , 579 – 609 ( 2013 ).
   Google Scholar
• Arnould B , BenmedjahedK , GallaisJ-L , GinièsP , BaronR . The impact of herpes zoster and subsequent chronic pain on patients’ daily lives . J. Public Health18 , 567 – 574 ( 2010 ).
   Google Scholar
• Nalamachu S , Morley-ForsterP . Diagnosing and managing postherpetic neuralgia . Drugs Aging29 , 863 – 869 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Mick G , BaronR , Correa-IllanesGet al. Is an easy and reliable diagnosis of localized neuropathic pain (LNP) possible in general practice? Development of a screening tool based on IASP criteria . Curr. Med. Res. Opin.30 , 1357 – 1366 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Dworkin RH , O’ConnorAB , AudetteJet al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update . Mayo Clin. Proc.85 ( Suppl. 3 ), S3 – S14 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Attal N , CruccuG , BaronRet al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision . Eur. J. Neurol.17 , 1113 – 1188 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Finnerup NB , AttalN , HaroutounianSet al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis . Lancet Neurol.14 , 162 – 173 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Liedgens H , HertelN , GabrielAet al. Cost–effectiveness analysis of a lidocaine 5% medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: a German perspective . Clin. Drug Investig.28 , 583 – 601 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Binder A , BruxelleJ , RogersP , HansG , BöslI , BaronR . Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial . Clin. Drug Investig.29 , 393 – 408 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Peloso PM , BellamyN , BensenWet al. Double-blind randomized placebo controlled trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee . J. Rheumatol.27 , 764 – 771 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Ware JE , SherbourneCD . The MOS 36-item Short-Form Health Survey (SF-36®). Conceptual framework and item selection . Med. Care30 , 473 – 484 ( 1992 ).
   PubMed Web of Science ®Google Scholar
• Ware JE , KosinkiM , KellerSD . SF-36: Physical and Mental Health Summary Scales: A User’s Manual (5th Edition) . Health Assessment Lab – New England Medical Center , Boston, MA, USA ( 1994 ).
   Google Scholar
• Melzack R . The short form McGill Pain Questionnaire . Pain30 , 191 – 197 ( 1987 ).
   PubMed Web of Science ®Google Scholar
• Johnson RW , BouhassiraD , KassianosG , LeplègeA , SchmaderKE , WeinkeT . The impact of herpes zoster and post-herpetic neuralgia on quality-of-life . BMC Med.8 , 37 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Roth T , van SeventerR , MurphyTK . The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials . Curr. Med. Res. Opin.26 , 2411 – 2419 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Smith MT , HaythornthwaiteJA . How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature . Sleep Med. Rev.8 , 119 – 132 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Rowbotham MC , HardenN , StaceyB , BernsteinP , Magnus-MillerL . Gabapentin for the treatment of postherpetic neuralgia . JAMA280 , 1837 – 1842 ( 1998 ).
   PubMed Web of Science ®Google Scholar
• Hans G , SabatowskiR , BinderA , BoeslI , RogersP , BaronR . Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study . Curr. Med. Res. Opin.25 , 1295 – 1305 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Sabatowski R , HansG , TackenI , KapanadzeS , BuchheisterB , BaronR . Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia . Curr. Med. Res. Opin.28 , 1337 – 1346 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Dakin H , NuijtenM , LiedgensH , NautrupBP . Cost–effectiveness of a lidocaine 5% medicated plaster relative to gabapentin for postherpetic neuralgia in the United Kingdom . Clin. Ther.29 , 1491 – 1507 ( 2007 ).
   PubMed Web of Science ®Google Scholar